| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 77.675 | 73.306 | 90.417 | 152.186 | 104.855 | 52.728 | 7.439 | 844 | 439 | 4.401 |
| Total Income - EUR | 78.025 | 73.794 | 90.532 | 153.499 | 108.502 | 54.969 | 13.442 | 844 | 439 | 4.401 |
| Total Expenses - EUR | 57.239 | 69.197 | 90.535 | 138.147 | 100.074 | 56.082 | 12.606 | 707 | 185 | 4.313 |
| Gross Profit/Loss - EUR | 20.786 | 4.597 | -3 | 15.352 | 8.428 | -1.113 | 836 | 137 | 254 | 88 |
| Net Profit/Loss - EUR | 17.434 | 3.696 | -1.994 | 13.817 | 7.342 | -2.103 | 582 | 117 | 216 | 75 |
| Employees | 2 | 3 | 4 | 5 | 2 | 2 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Dencarmil S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 2.234 | 6.612 | 6.446 | 7.677 | 13.425 | 1.440 | 0 | 0 | 0 | 0 |
| Current Assets | 17.488 | 16.159 | 8.091 | 18.043 | 31.651 | 31.118 | 27.150 | 16.953 | 17.137 | 17.034 |
| Inventories | 0 | 283 | 1.584 | 1.848 | 2.575 | 0 | 0 | 0 | 0 | 210 |
| Receivables | 17.446 | 12.950 | 5.015 | 9.189 | 27.905 | 30.222 | 26.310 | 15.940 | 15.891 | 15.807 |
| Cash | 42 | 2.926 | 1.492 | 7.007 | 1.171 | 896 | 840 | 1.013 | 1.246 | 1.017 |
| Shareholders Funds | 15.238 | 3.741 | -1.950 | 11.903 | 19.015 | 16.551 | 16.766 | 16.875 | 17.040 | 17.020 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 4.483 | 19.031 | 16.488 | 13.818 | 26.061 | 16.007 | 10.384 | 78 | 97 | 13 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4941 - 4941" | |||||||||
| CAEN Financial Year |
4941
|
|||||||||
Comments - Dencarmil S.r.l.